Элеонора Трушина

Mrs. Элеонора Трушина


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2012 in Quantum Electronics
Verified
Journal Article
Closed access
PKP G Kuzmin
P G Kuzmin
GSGeorgy Shafeev
Georgy Shafeev
VVValery V Voronov
Valery V Voronov
RRR V Raspopov
R V Raspopov
EAE A Arianova
E A Arianova
SKS A Khotimchenko
S A Khotimchenko

26 October 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
IGIvan V. Gmoshinski
Ivan V. Gmoshinski
Vladimir A ShipelinVladimir A Shipelin
Vladimir A Shipelin
ASAntonina Shumakova
Antonina Shumakova
ЭТЭлеонора Трушина
Элеонора Трушина
OMOksana Konstantinovna Mustafina
Oksana Konstantinovna Mustafina
VTViktor A. Tutelyan
Viktor A. Tutelyan
The experimental data on the oral toxicity of nanostructured amorphous silica (SiO2), widely used in food supplements, pharmaceuticals, and cosmetics, in terms of its in vivo effect on the immune system, are contradictory. Therefore, this study aimed to assess the rat’s immune function after SiO2 oral administration. In the first experiment, SiO2 was daily orally administered to Wistar rats for 92 days in doses of 0.1, 1.0, 10, and 100 mg/kg of body weight (bw). In the second 28-day experiment, SiO2 in a dose of 100 mg/kg bw was daily orally administered to rats parenterally immunized with the food allergen ovalbumin (OVA) for the reproduction of systemic anaphylaxis reaction. Together with integral indices, we assessed intestinal permeability to protein macromolecules; hematology; CD45RA+, CD3+, CD4+, CD8+, and CD161a+ cells; cytokines TNF-α, IL-6, and IL-10; and IgG to OVA. The results obtained showed that SiO2 has no effect on the severity of the anaphylactic reaction, but is capable inducing a toxic effect on the T-cell immune systems of rats. Estimated no observed adverse effect level NOAEL for SiO2 ranges up to 100 mg/kg bw in terms of its daily consumption for 1–3 months. Using SiO2 as a food additive should be the subject of regulation.

1 January 2023 in Problems of Nutrition
Verified
Journal Article
Open access
ЭТЭлеонора Трушина
Элеонора Трушина
NRN.A. Riger
N.A. Riger
OMO.K. Mustaphina
O.K. Mustaphina
ATAndrey Timonin
Andrey Timonin
Влияние микро- и нанопластиков - контаминантов пищевой продукции на иммунную систему

1 November 2013 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
Vladimir A ShipelinVladimir A Shipelin
Vladimir A Shipelin
ЭТЭлеонора Трушина
Элеонора Трушина
LAL. I. Avren’EVa
L. I. Avren’EVa
SSS. Kh. Soto
S. Kh. Soto
SBS. Yu. Batishcheva
S. Yu. Batishcheva
VTV. A. Tutel’YAn
V. A. Tutel’YAn
In a subacute toxicological and sanitary experiment, the hydroxylated fullerene C60, fullerenol C60(OH)24is intragastrally administered to male Wistar rats at doses of 0.1, 1, and 10 mg/kg daily for...

1 January 2021 in Problems of Nutrition
Verified
Journal Article
Closed access
NRN.A. Riger
N.A. Riger
ЭТЭлеонора Трушина
Элеонора Трушина
OMO.K. Mustaphina
O.K. Mustaphina
ATAndrey Timonin
Andrey Timonin
IAIlya Aksenov
Ilya Aksenov
IUI.M. Sechenov First Moscow State Medical of Ministry of Healthcare of the Russian Federation University (Sechenov University)
I.M. Sechenov First Moscow State Medical of Ministry of Healthcare of the Russian Federation University (Sechenov University)
Патогенетические механизмы развития гематологических нарушений при индуцированной жировой дистрофии печени у крыс линии Wistar и оценка регуляторного

22 May 2023 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
ЭТЭлеонора Трушина
Элеонора Трушина
NRN. A. Riger
N. A. Riger
ATAndrey Timonin
Andrey Timonin
ADAlexander A Devyatov
Alexander A Devyatov
IAIlya Aksenov
Ilya Aksenov
VTViktor A. Tutelyan
Viktor A. Tutelyan
BACKGROUND:The model of obesity under experimental conditions is reproduced by using high-calorie diets in animals. It has been established that metabolic disorders cause meta-inflammation not only in peripheral organs and tissues, but also in brain structures. The search for effective neuroprotective antioxidants to suppress inflammatory processes in the cerebral cortex in obesity is an urgent task due to the widespread prevalence of this disease.AIM: to evaluate the effect of minor biologically active substances — carnosine (CAR) and α-lipoic acid (ALA) on the cytokine profile of the frontal cortex of the left hemisphere of the brain in Wistar male rats with obesity induced by a high-calorie choline-deficient diet.MATERIALS AND METHODS:The studies were carried out on male Wistar rats with an initial body weight of 150±10 g. The animals were randomized by body weight into 5 groups. For 8 weeks, rats of the 1st (control) group received a complete modified diet of AIN93M; rats of the 2nd group consumed a high-calorie choline-deficient diet (HCHDR), the fat content of which was 45%, fructose — 20% of the energy value of the diet; rats of the 3rd group received HCHDR with the addition of CAR at a dose of 75 mg per 1 kg of body weight; rats of the 4th group received HCHDR with the addition of ALA at a dose of 75 mg per 1 kg of body weight; rats of the 5th group received HCHDR with the addition of the CAR + ALA complex in a total dose of 150 mg per 1 kg of body weight. Animals were removed from the experiment by decapitation under ether anesthesia. The levels of triglycerides (Tg) and free fatty acids (FFA) in blood plasma (mmol) were determined on a biochemical analyzer (Konelab 20i, Thermo Clinical Labsystems Oy, Finland). Content of cytokines and chemokines (pg/ml): GM-CSF, IL-10, IL-17A, IL-12p40, IL-12p70, IL-1α, IL-2, IL-4, IL-5, IFN-γ, MCP-1, M-CSF, MIP-1α, MIP-2, MIP-3α, RANTES, and TNF-α in cerebral cortex lysates were determined by multiplex immunoassay using a Luminex 200 analyzer (Luminex Corporation, USA). To assess the relationship between the level of cytokines in blood plasma and changes in their concentrations under the influence of HCCDR in lysates of the cortex of the frontal lobe of the left hemisphere of the brain, the ratio was calculated: the level of cytokines pg/ml in blood plasma [1]/the content of cytokines pg/ml in lysates (pl/ lys) for each sample.RESULTS: On the model of obesity in rats, the presence of an inflammatory process in the cerebral cortex was established, as evidenced by an increase in the content of pro-inflammatory factors: IL-2, M-CSF, MIP-1α and RANTES and a decrease in the content of immunoregulatory cytokines of varying severity: IL-10, IL17A, IL-12p40, IL-12p70, TNF-a, MIP-2 and MIP-3α in group 2 rats. (HCHDR) compared with the control group. Enrichment of HCHDR with biologically active substances: CAR, ALA or their complex, ensured the normalization of lipid metabolism, as evidenced by the decrease in the ratio of circulating Tg to FFA in the blood serum of rats to control values: 1st gr. (control) — 1,04±0.23; 2nd gr. (HCHDR) — 1,64±0.63; 3rd gr. (CAR) — 0,98±0.31; 4th gr. (ALA) — 0,86±0.31; 5th gr. (CAR+ALA) — 1,02±0.38. Enrichment of HCHDR with CAR, ALA or their complex led to a decrease in the content of pro-inflammatory and apoptosis-regulating cytokines and chemokines in the cortex of the frontal lobe of the rat brain: IL-1α, IL-2, IL-17A, M-CSF, MCP-1, MIP3α and RANTES, along with an increase in the level of the anti-inflammatory cytokine IL-10, which indicates the suppression of the inflammatory process induced by the consumption of HCHDR in rats.CONCLUSION:The data obtained indicate the prospect of using CAR and ALA or their complex as neuroprotective antioxidants to reduce the inflammatory process in brain structures in obesity.